PUBLISHER: Renub Research | PRODUCT CODE: 1338998
PUBLISHER: Renub Research | PRODUCT CODE: 1338998
Vitiligo Treatment Market, Size, Share, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
Vitiligo Treatment Market size will be US$ 822.75 Million by 2028, according to Renub Research. Vitiligo, a prevalent skin condition affecting around 70 million individuals globally, stems from the immune-triggered deterioration of melanocytes. The most prevalent subtype, non-segmental vitiligo, typically follows a chronic trajectory and often inflicts notable psychosocial ramifications on sufferers. Timely identification, awareness of associated conditions, accurate gauging of disease scope and intensity, scrutiny of quality-of-life impairments, and swift implementation of treatment grounded in current evidence-based practices are pivotal pillars in vitiligo management. Notably, 20-35% of patients are children. In July 2022, the FDA's green lighting of the 1.5% ruxolitinib cream marked a significant milestone as the first topical solution for non-segmental vitiligo in individuals aged 12 and above, providing gratifying results for dedicated vitiligo advocates.
Vitiligo Treatment Market is growing at a CAGR of 4.96% from 2022 to 2028
The escalating global prevalence of vitiligo is a driving force behind market expansion, as an increasing number of individuals receive diagnoses. Progress in treatment alternatives, encompassing topical medications, phototherapy, and surgical interventions, empowers patients with diversified options and enhanced outcomes. Heightened cognizance of vitiligo within both medical circles and the public sphere facilitates prompt identification and intervention, propelling the need for therapeutic approaches and management tactics.
Ongoing research delves into vitiligo's origins and novel treatments, advancing the market. Advocacy groups support companies, offering resources and improving accessibility. Technological advancements, like lasers and drug delivery, enhance treatment. Its aesthetic impact drives demand for cosmetics like makeup and pigments. Vitiligo Treatment Market has reached US$ 615.2 Million in 2022.
New pipeline of Vitiligo Treatment
AbbVie reiterated commitment to pores and skin ailment studies, which includes vitiligo, at EADV 2022. Glimpses on their website hinted at a RoRT inhibitor have a look at for immune problems. 2023 IIS Strategic Priorities label vitiligo as "Non-Product Only."
- Ahammune Biosciences Pvt. Ltd., Pune-primarily based, pioneers AB1001 for early vitiligo tiers, targeting T-cell activation. Phase I trials finished in January 2023.
- Applied Biology's Photocil mimics phototherapy, acquired via Jupiter Wellness in July 2022, renamed PhotoFirst after India's CDSCO approval in November 2022.
- Avita Medical's RECELL® System sprays autologous cells on vitiligo lesions, submitted for FDA approval in December 2022, following preliminary approval in 2018.
- Edesa Biotech advances EB06 antibody with Health Canada's Phase 2 approval in February 2023. EB06 goals autoreactive T cells via CXCL10.
- In October 2022, Incyte acquired Villaris Therapeutics, gaining rights to auremolimab (VM6) for vitiligo remedy, making ready for clinical trials in 2023.
- Personalized care drives the segmental vitiligo treatment market growth, meeting specific needs of patients with this form of the condition.
By Type, Vitiligo Treatment Market is divided into Segmental and Non-Segmental. Segmental vitiligo treatment is the market fastest-growing segment, offering targeted solutions for localized depigmentation. The rising awareness of its unique characteristics propels its rapid expansion. Evolving medical advancements emphasize tailored therapies, reflecting a dynamic market. The segmental vitiligo treatment market is projected to sustain growth, catering to patients' specific needs in this form of the condition.
Topical treatments hold a prominent position in the global vitiligo industry
By Treatment Type, Vitiligo Treatment Market is segmented into Topical Treatments, Light Therapy, Surgical Procedures and Others. Topical treatments dominate the vitiligo industry due to their convenience, non-invasiveness, and efficacy in localized treatment. These encompass corticosteroids, calcineurin inhibitors, and vitamin D analogs, delivering precise outcomes. The preference for non-surgical approaches strengthens their popularity, aided by patient compliance and ease of use. Topical solutions are ideal for limited disease spread and milder interventions, while ongoing research and innovation ensure their continued leadership in addressing vitiligo's diverse severity levels.
Growing demand for patient-centric care underscores ambulatory clinics' pivotal role in shaping the future of vitiligo treatment
By End User, Vitiligo Treatment Market is segmented into Hospitals, Ambulatory Clinics and Others. Ambulatory clinics rapidly dominate the vitiligo sector, offering outpatient convenience, specialized treatments, and expert consultations. This growth caters to patients seeking effective solutions without hospitalization, aligning with the demand for non-invasive and personalized medical services. This trend fosters ambulatory clinics as a trusted choice, allowing patients to maintain routines. Easy access to targeted therapies and ongoing care adds to their popularity. Evolving with technology and innovative approaches, these clinics' upward trajectory is set to continue. The surge in demand for accessible, patient-centric care highlights the vital role of ambulatory clinics in shaping the future of vitiligo treatment.
As trends evolve and industries progress, the United States is anticipated to retain its position as a significant market leader across vitiligo treatment sectors
By Country, Global Vitiligo Treatment Market is segmented into United States, Canada, Mexico, Germany, U.K., France, Italy, Spain, Japan, China, Australia, India, Brazil, Saudi Arabia, Argentina, U.A.E, South Africa and Rest of World. The United States is set to dominate the vitiligo market in the near future. Driven by factors such as economic strength, technological advancements, and a well-established healthcare system, it is poised to hold the leading position. The country's substantial investments in diverse industries and its role as a research and development hub contribute to its projected market supremacy. With a considerable consumer base and evolving industry trends, the United States is expected to maintain its position as a primary player in the vitiligo treatment market for years to come.
Key Player
Incyte Corporation, Bristol-Myers Squibb, Clinuvel Pharmaceuticals Ltd, Astellaspharmainc, Baxter International Inc, Pfizer and Dr. Reddy's Laboratories Ltd. are the some of the major companies that operate in the global vitiligo treatment market.
Renub Research latest report "Vitiligo Treatment Market, Global Forecast by Type (Segmental, Non - Segmental), by Treatment Type (Topical Treatments , Light Therapy, Surgical Procedures, Others), by End-User (Hospitals, Ambulatory Clinics, Others), by Country (United States, Canada, Mexico, Germany, U.K., France, Italy, Spain, Japan, China, Australia, India, Brazil, Saudi Arabia, Argentina, U.A.E, South Africa and Rest of World), Vitiligo Pipe Line Drugs (ARN-4079, ATI-502, AX-1602, BOS-475, CCP-070, Cerdulatinib (RVT-502), HuABC-2, Abatacept, Topical Ruxolitinib, VLRX-001), Companies (Incyte Corporation, Bristol-Myers Squibb, Clinuvel Pharmaceuticals Ltd, Astellaspharmainc, Baxter International Inc, Pfizer and Dr. Reddy's Laboratories Ltd)" provides a detailed analysis of Global Vitiligo Treatment Industry.
Country - Patient Numbers & Market has been covered from 18 viewpoints:
- 1. United States
- 2. Canada
- 3. Mexico
- 4. Germany
- 5. U.K.
- 6. France
- 7. Italy
- 8. Spain
- 9. Japan
- 10. China
- 11. Australia
- 12. India
- 13. Brazil
- 14. Saudi Arabia
- 15. Argentina
- 16. U.A.E
- 17. South Africa
- 18. Rest of World
Country - Volume has been covered from 18 viewpoints:
- 1. United States
- 2. Canada
- 3. Mexico
- 4. Germany
- 5. U.K.
- 6. France
- 7. Italy
- 8. Spain
- 9. Japan
- 10. China
- 11. Australia
- 12. India
- 13. Brazil
- 14. Saudi Arabia
- 15. Argentina
- 16. U.A.E
- 17. South Africa
- 18. Rest of World
Vitiligo Type - Market has been covered from 2 viewpoints:
- 1. Segmental
- 2. Non - segmental
Treatment Type - Market has been covered from 4 viewpoints:
- 1. Topical Treatments
- 2. Light Therapy
- 3. Surgical Procedures
- 4. Others
End User - Market has been covered from 4 viewpoints:
- 1. Hospitals
- 2. Ambulatory Clinics
- 3. Others
Vitiligo Pipe Line Drugs market has been covered from 10 viewpoints:
- 1. ARN-4079
- 2. ATI-502
- 3. AX-1602
- 4. BOS-475
- 5. CCP-070
- 6. Cerdulatinib (RVT-502)
- 7. HuABC-2
- 8. Abatacept
- 9. Topical Ruxolitinib
- 10. VLRX-001
Company Insight:
- Overview
- Recent Development
- Revenue
Companies Covered:
- 1. Incyte Corporation
- 2. Bristol-Myers Squibb
- 3. Clinuvel Pharmaceuticals Ltd.
- 4. Astellaspharmainc
- 5. Baxter International Inc
- 6. Pfizer
- 7. Dr. Reddy's Laboratories Ltd.
Table of Contents
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
- 4.1 Growth Drivers
- 4.2 Challenges
5. Global Vitiligo Patient Numbers & Market
- 5.1 VitiligoTreatment Market
- 5.2 Vitiligo Patients (Thousand)
6. Market Share - Global Vitiligo Patient Analysis
- 6.1 Market Share
- 6.1.1 Vitiligo Type
- 6.1.2 Treatment Type
- 6.1.3 End User
- 6.1.4 Country Vitiligo Market Share
- 6.2 Volume Share
- 6.2.1 By Country Vitiligo Patient Numbers Share
7. Diseases Type - Global Vitiligo Market
- 7.1 Segmental
- 7.2 Non Segmental
8. Treatment Type - Global Vitiligo Market
- 8.1 Topical Treatments
- 8.2 Light Therapy
- 8.3 Surgical Procedures
- 8.4 Others
9. End User - Global Vitiligo Market
- 9.1 Hospitals
- 9.2 Ambulatory Clinics
- 9.3 Others
10. Country - Vitiligo Patient Numbers & Market
- 10.1 United States
- 10.1.1 Vitiligo Market
- 10.1.2 Vitiligo Patient (Thousand)
- 10.2 Canada
- 10.2.1 Vitiligo Market
- 10.2.2 Vitiligo Patient (Thousand)
- 10.3 Mexico
- 10.3.1 Vitiligo Market
- 10.3.2 Vitiligo Patient (Thousand)
- 10.4 Germany
- 10.4.1 Vitiligo Market
- 10.4.2 Vitiligo Patient (Thousand)
- 10.5 United Kingdom
- 10.5.1 Vitiligo Market
- 10.5.2 Vitiligo Patient (Thousand)
- 10.6 France
- 10.6.1 Vitiligo Market
- 10.6.2 Vitiligo Patient (Thousand)
- 10.7 Italy
- 10.7.1 Vitiligo Market
- 10.7.2 Vitiligo Patient (Thousand)
- 10.8 Spain
- 10.8.1 Vitiligo Market
- 10.8.2 Vitiligo Patient (Thousand)
- 10.9 Japan
- 10.9.1 Vitiligo Market
- 10.9.2 Vitiligo Patient (Thousand)
- 10.10 China
- 10.10.1 Vitiligo Market
- 10.10.2 Vitiligo Patient (Thousand)
- 10.11 Australia
- 10.11.1 Vitiligo Market
- 10.11.2 Vitiligo Patient (Thousand)
- 10.12 India
- 10.12.1 Vitiligo Market
- 10.12.2 Vitiligo Patient (Thousand)
- 10.13 Brazil
- 10.13.1 Vitiligo Market
- 10.13.2 Vitiligo Patient (Thousand)
- 10.14 Saudi Arabia
- 10.14.1 Vitiligo Market
- 10.14.2 Vitiligo Patient (Thousand)
- 10.15 Argentina
- 10.15.1 Vitiligo Market
- 10.15.2 Vitiligo Patient (Thousand)
- 10.16 United Arab Emirates
- 10.16.1 Vitiligo Market
- 10.16.2 Vitiligo Patient (Thousand)
- 10.17 South Africa
- 10.17.1 Vitiligo Market
- 10.17.2 Vitiligo Patient (Thousand)
- 10.18 Rest of World
- 10.18.1 Vitiligo Market
- 10.18.2 Vitiligo Patient (Thousand)
11. Vitiligo Pipe Line Drugs
- 11.1 ARN-4079
- 11.2 ATI-502
- 11.3 AX-1602
- 11.4 BOS-475
- 11.5 CCP-070
- 11.6 Cerdulatinib (RVT-502)
- 11.7 HuABC-2
- 11.8 Abatacept
- 11.9 Topical Ruxolitinib
- 11.10 VLRX-001
12. Clinical Study of Vitiligo Market
13. Porter's Five Forces
- 13.1 Bargaining Power of Buyer
- 13.2 Bargaining Power of Supplier
- 13.3 Threat of New Entrants
- 13.4 Rivalry among Existing Competitors
- 13.5 Threat of Substitute Products
14. SWOT Analysis
- 14.1 Strengths
- 14.2 Weaknesses
- 14.3 Opportunities
- 14.4 Threats
15. Company Analysis
- 15.1 Incyte Corporation
- 15.1.1 Overviews
- 15.1.2 Resent Development
- 15.1.3 SWOT Analysis
- 15.1.4 Revenue
- 15.2 Bristol-Myers Squibb
- 15.2.1 Overviews
- 15.2.2 Resent Development
- 15.2.3 SWOT Analysis
- 15.2.4 Revenue
- 15.3 Clinuvel Pharmaceuticals Ltd
- 15.3.1 Overviews
- 15.3.2 Resent Development
- 15.3.3 SWOT Analysis
- 15.3.4 Revenue
- 15.4 Astellaspharmainc
- 15.4.1 Overviews
- 15.4.2 Resent Development
- 15.4.3 SWOT Analysis
- 15.4.4 Revenue
- 15.5 Baxter International Inc.
- 15.5.1 Overviews
- 15.5.2 Resent Development
- 15.5.3 SWOT Analysis
- 15.5.4 Revenue
- 15.6 Pfizer
- 15.6.1 Overviews
- 15.6.2 Resent Development
- 15.6.3 SWOT Analysis
- 15.6.4 Revenue
- 15.7 Dr. Reddy's Laboratories Ltd
- 15.7.1 Overviews
- 15.7.2 Resent Development
- 15.7.3 SWOT Analysis
- 15.7.4 Revenue
List of Figures
- Figure-01: Global Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-02: Global - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-03: Global Vitiligo Patients Population Volume (Thousand), 2018 - 2022
- Figure-04: Global - Forecast for Vitiligo Patients Population Volume (Thousand), 2023 - 2028
- Figure-05: Diseases Type - Segmental Market (Million US$), 2018 - 2022
- Figure-06: Diseases Type - Forecast for Segmental Market (Million US$), 2023 - 2028
- Figure-07: Diseases Type - Non Segmental Market (Million US$), 2018 - 2022
- Figure-08: Diseases Type - Forecast for Non Segmental Market (Million US$), 2023 - 2028
- Figure-09: Treatment Type - Topical Treatments Market (Million US$), 2018 - 2022
- Figure-10: Treatment Type - Forecast for Topical Treatments Market (Million US$), 2023 - 2028
- Figure-11: Treatment Type - Light Therapy Market (Million US$), 2018 - 2022
- Figure-12: Treatment Type - Forecast for Light Therapy Market (Million US$), 2023 - 2028
- Figure-13: Treatment Type - Surgical Procedures Market (Million US$), 2018 - 2022
- Figure-14: Treatment Type - Forecast for Surgical Procedures Market (Million US$), 2023 - 2028
- Figure-15: Treatment Type - Others Market (Million US$), 2018 - 2022
- Figure-16: Treatment Type - Forecast for Others Market (Million US$), 2023 - 2028
- Figure-17: End User - Hospitals Market (Million US$), 2018 - 2022
- Figure-18: End User - Forecast for Hospitals Market (Million US$), 2023 - 2028
- Figure-19: End User - Ambulatory Clinics Market (Million US$), 2018 - 2022
- Figure-20: End User - Forecast for Ambulatory Clinics Market (Million US$), 2023 - 2028
- Figure-21: End User - Others Market (Million US$), 2018 - 2022
- Figure-22: End User - Forecast for Others Market (Million US$), 2023 - 2028
- Figure-23: United States - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-24: United States - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-25: United States - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-26: United States - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-27: Canada - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-28: Canada - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-29: Canada - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-30: Canada - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-31: Mexico - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-32: Mexico - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-33: Mexico - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-34: Mexico - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-35: Germany - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-36: Germany - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-37: Germany - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-38: Germany - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-39: United Kingdom - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-40: United Kingdom - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-41: United Kingdom - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-42: United Kingdom - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-43: France - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-44: France - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-45: France - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-46: France - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-47: Italy - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-48: Italy - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-49: Italy - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-50: Italy - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-51: Spain - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-52: Spain - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-53: Spain - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-54: Spain - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-55: Japan - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-56: Japan - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-57: Japan - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-58: Japan - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-59: China - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-60: China - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-61: China - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-62: China - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-63: Australia - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-64: Australia - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-65: Australia - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-66: Australia - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-67: India - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-68: India - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-69: India - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-70: India - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-71: Brazil - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-72: Brazil - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-73: Brazil - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-74: Brazil - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-75: Saudi Arabia - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-76: Saudi Arabia - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-77: Saudi Arabia - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-78: Saudi Arabia - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-79: Argentina - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-80: Argentina - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-81: Argentina - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-82: Argentina - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-83: United Arab Emirates - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-84: United Arab Emirates - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-85: United Arab Emirates - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-86: United Arab Emirates - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-87: South Africa - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-88: South Africa - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-89: South Africa - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-90: South Africa - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-91: Rest of World - Vitiligo Treatment Market (Million US$), 2018 - 2022
- Figure-92: Rest of World - Forecast for Vitiligo Treatment Market (Million US$), 2023 - 2028
- Figure-93: Rest of World - Vitiligo Treatment Patients Population Volume (Thousand), 2018 - 2022
- Figure-94: Rest of World - Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 - 2028
- Figure-95: Incyte Corporation - Global Revenue (Million US$), 2018 - 2022
- Figure-96: Incyte Corporation - Forecast for Global Revenue (Million US$), 2023 - 2028
- Figure-97: Bristol-Myers Squibb - Global Revenue (Million US$), 2018 - 2022
- Figure-98: Bristol-Myers Squibb - Forecast for Global Revenue (Million US$), 2023 - 2028
- Figure-99: Clinuvel Pharmaceuticals Limited - Global Revenue (Thousand US$), 2018 - 2022
- Figure-100: Clinuvel Pharmaceuticals Limited - Forecast for Global Revenue (Thousand US$), 2023 - 2028
- Figure-101: Astellas pharma Inc. - Global Revenue (Thousand US$), 2018 - 2022
- Figure-102: Astellas pharma Inc. - Forecast for Global Revenue (Thousand US$), 2023 - 2028
- Figure-103: Baxter International Inc. - Global Revenue (Thousand US$), 2018 - 2022
- Figure-104: Baxter International Inc. - Forecast for Global Revenue (Thousand US$), 2023 - 2028
- Figure-105: Pfizer - Global Revenue (Thousand US$), 2018 - 2022
- Figure-106: Pfizer. - Forecast for Global Revenue (Thousand US$), 2023 - 2028
- Figure-107: Dr. Reddy's Laboratories Ltd - Global Revenue (Thousand US$), 2018 - 2022
- Figure-108: Dr. Reddy's Laboratories Ltd - Forecast for Global Revenue (Thousand US$), 2023 - 2028
List of Tables
- Table-01: Global - Vitiligo Treatment Market Share by Vitiligo Type (Percent), 2018 - 2022
- Table-02: Global - Forecast for Vitiligo Treatment Market Share by Vitiligo Type (Percent), 2023 - 2028
- Table-03: Global - Vitiligo Treatment Market Share by Treatment Type (Percent), 2018 - 2022
- Table-04: Global - Forecast for Vitiligo Treatment Market Share by Treatment Type (Percent), 2023 - 2028
- Table-05: Global - Vitiligo Treatment Market Share by End-User (Percent), 2018 - 2022
- Table-06: Global - Forecast for Vitiligo Treatment Market Share by End-User (Percent), 2023 - 2028
- Table-07: Global - Vitiligo Treatment Market Share by Country (Percent), 2018 - 2022
- Table-08: Global - Forecast for Vitiligo Treatment Market Share by Country (Percent), 2023 - 2028
- Table-09: Global - Vitiligo Treatment Patient Numbers Share by Country (Percent), 2018 - 2022
- Table-10: Global - Forecast for Vitiligo Treatment Patient Numbers Share by Country (Percent), 2023 - 2028
